News
A new retrospective study shows a high cure rate exceeding 97 percent among older patients (mean age: 82.5 years) being …
First-line therapy with Pembrolizumab may produce better responses and result in longer survival in Merkel cell carcinom…
Following Hawaii’s lead, Florida’s Key West City Commission voted to ban the sale of products that contain o…
States with fewer melanoma diagnoses actually have higher death rates, report researchers at University of Utah Health.
…
Bristol-Myers Squibb Company will acquire Celgene Corp. in a cash and stock transaction with an equity value of approxim…
Researchers out of Rutgers Cancer Institute of New Jersey and colleagues from across the country are conducting a study …
The naked eye alone is not enough to accurately diagnosis skin cancer and smart phone apps may also miss melanomas, acco…
Sensus Healthcare, Inc., a medical device company specializing in the non-invasive treatment of non-melanoma skin cancer…
